IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 43, Issue 4, 1998, Pages 706-714

  Lügering, Norbert ^a   Kucharzik, Torsten ^b   Stein, Henning ^b   Winde, Günther ^b   Lügering, Andreas ^b   Hasilik, Andrej ^b   Domschke, Wolfram ^b   Stoll, Reinhard ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NONE

Author keywords

Combined treatment; Inflammatory bowel disease; Lysosomal enzymes; Monocytes; Th 2 cytokines

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LYSOSOME ENZYME;

ADULT; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; ENTERITIS; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME RELEASE; FEMALE; HUMAN; LAMINA PROPRIA; MALE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ALPHA-MANNOSIDASE; BETA-GALACTOSIDASE; BETA-N-ACETYLHEXOSAMINIDASE; CASE-CONTROL STUDIES; CATHEPSIN D; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DOWN-REGULATION; FEMALE; GLUCURONIDASE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; MANNOSIDASES; MONOCYTES;

EID: 0031926406     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018845526434     Document Type: Article

References (38)

1. Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 30:835-838, 1989
2. Hermanowics A, Gibson PR, Jewell DP: The role of phagocytes in inflammatory bowel disease. Clin Sci 69:241-249, 1985
3. Miura M, Hiwatashi N: Impaired monocyte macrophages function in patients with Crohn's disease. J Clin Lab Immunol 24:167-170, 1987
4. Mahida YR, Wu K, Jewell DP: Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 30:1362-1370, 1989
5. + monocyte cells. Gut 37:367-373, 1995
6. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertowich M, Nash GS: Increased activation of intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 101:1020-1030, 1991
7. Rugtveit J, Brandtzaeg P, Halstensen TS, Fausa O, Scott H: Increased macrophage subset in inflammatory bowel disease: Apparent recruitment from peripheral blood monocytes. Gut 35:669-674, 1994
8. Williams JG, Hughes LE, Hallett MB: Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 31:187-193, 1990
9. Ganguly N, Lloyd B, Price C, Kingham J, Lloyd R, Triger D: Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lancet, i,1073-1075, 1978
10. Mee AS, Jewell DP: Monocytes in inflammatory bowel disease: Monocyte and serum lysosomal enzyme activity. Clin Sci 58:295-300, 1980
11. Mee AS, Nuttall L, Potter BJ, Jewell DP: Studies on monocytes in inflammatory bowel disease: Factors influencing monocyte lysosomal enzyme activity. Clin Exp Immunol 39:785-791, 1980
12. Scapa E, Neuman M, Eshchar J: Inflammatory bowel disease and serum beta-N-acetylhexosaminidase. Enzyme 43:146-150, 1990
13. Lügering N, Stoll R, Siekmann A, Faulhaber J, Heese C, Dietrich O, Kucharzik T, Busch H, Hasilik A, Domschke W: Elevated levels of activities of beta-hexosaminidase and alpha-mannosidase in human immunodeficiency virus-infected patients. J Infect Dis 171:683-686, 1995
14. Kornfeld S: Trafficking of lysosomal enzymes in normal and disease states. J Clin Invest 77:1-6, 1986
15. Hasilik A, Neufeld EF: Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. J Biol Chem 255:4937-4945, 1980
16. Imort M, Hasilik A, von Figura K: Molecular forms of β-hexoaminidase and cathcpsin D in serum and urine of healthy controls and patients with elevated activity of lysosomal enzymes. Biochem J 213:733-740, 1983
17. Bogdan C, Nathan C: Modulation and macrophage function by transforming growth factor beta, interleukin-4 and interleukin-10. Ann NY Acad Sci 685:713-739, 1993
18. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A: Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 108:21-33, 1995
19. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by human monocytes, J. Exp Med 174: 1209-1220, 1991 synthesis by human monocytes: An autoregulatory role of IL-10 produced by human monocytes. J Exp Med 174:1209-1220, 1991
20. Schreiber S, Heinig T, Thiele HG, Raedler A: Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108:1434-1444, 1995
21. Kucharzik T, Lügering N, Weigelt H, Adolf M, Domschke W, Stoll R: Immunoregulatory properties of Interleukin-13 in patients with inflammatory bowel disease. Comparison with interleukin-4 and interleukin-10. Clin Exp Immunol 104:483-490, 1996
22. Minty A, Chalon P, Derocq J, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362:248-250, 1993
23. de Waal, Malefyt R, Figdor CG, Huijbens R, Mohan Peterson S, Bennett B, Culpepper J, Dang W, Zurawsky G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation with IFN-γ or IL-10. J Immunol 151:6370-6381, 1993
24. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G: Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor-α production. J Exp Med 181:537-546, 1945
25. Best WR, Becktel JM, Singleton JW, Kern FR: Development of a Crohn's disease activity index: National cooperative Crohn's disease study. Gastroenterology 106:782-785, 1976
26. Rachmilewitz D: Coated mesalazine (5-amino-salicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial. Br Med J 198:82-86, 1989
27. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A: Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononudear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181, 1993
28. 4. Nature 227:680-685, 1970
29. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
30. Kucharzik T, Lügering N, Adolf M, Domschke W, Stoll R: Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease. Dig Dis Sci 42:805-812, 1997
31. 2+-binding protein MRP8/14. Immunology 91:130-134, 1997
32. Mahida YR, Patel S, Gionchetti P, Vaux D, Jewell DP: Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut 30:826-834, 1989
33. Cappello M, Keshav S, Prince C, Jewell DP, Gordon S: Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 33:1214-1219, 1992
34. Endo T, Fumitaka O, Sone S: LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-γ. J Immunol 156:2240-2246, 1996
35. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ: Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol 99:331-339, 1995
36. Zurawski G, De Vries JE: Interleukin-13, an interleukin-4 like cytokine that acts on monocytes and B cells, but not on T-cells. Immunol Today 15:19-26, 1994
37. Nakagawara A, Nathan CF, Cohn ZA: Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. J Clin Invest 68:1243-1252, 1981
38. Baldassano RN, Schreiber S, Johnston RB, Muraki T, MacDermott RP: Monocytes of patients with Crohn's disease are primed for accentuated release of toxic oxygen metabolites: Possible role for endotoxin. Gastroenterology 105:60-66, 1993